Síndrome de aspiración meconial

Understanding Meconium Aspiration Syndrome

Overview of Meconium Aspiration Syndrome

• Meconium aspiration syndrome (MAS) occurs when a neonate inhales amniotic fluid stained with meconium during intrauterine life or at birth.

• Meconium is the first intestinal discharge of a newborn, containing pro-inflammatory components from various sources including gastrointestinal cells and bile salts.

Incidence and Risk Factors

• The incidence of meconium-stained amniotic fluid at delivery is approximately 13%, with 2 to 10% developing MAS. This risk increases with gestational age.

• Key risk factors include being post-term (over 42 weeks), perinatal asphyxia, cesarean delivery, lack of fetal monitoring, maternal fever, oligohydramnios, and intrauterine growth restriction.

Pathophysiology

• In post-term neonates experiencing perinatal asphyxia, hypoxia leads to increased peristalsis and relaxation of the anal sphincter, resulting in meconium expulsion.

• The inhalation of meconium can cause mechanical obstruction in the airways—either partial or total—which complicates breathing.

Clinical Manifestations

• Clinical signs include skin staining with meconium proportional to exposure duration; for instance, if only the umbilical cord is stained, it indicates less exposure than if the entire body shows staining.

• Other symptoms may include respiratory distress immediately after birth characterized by intercostal retractions and paradoxical abdominal breathing.

Diagnostic Approach

• Diagnosis involves confirming meconium-stained amniotic fluid presence at birth alongside respiratory difficulties and specific radiological findings.

Management of Newborns with Respiratory Distress

Assessment and Classification of Newborns

• The assessment includes checking for nasal flaring, grunting, retractions, or thoracoabdominal dissociation to classify the newborn's condition as without asphyxia, mild, moderate, or severe.

• A vigorous newborn is identified by an Apgar score above 7 at one minute, spontaneous respiratory effort, heart rate over 100 bpm, and good muscle tone; routine care is provided in this case.

• In contrast, a depressed newborn with an Apgar score below 6 at one minute may exhibit apnea and a heart rate under 100 bpm; management follows Hernanes' algorithm.

Immediate Interventions for Depressed Newborns

• For a newborn with apnea and low heart rate (<100 bpm), initial steps include placing them in a radiant warmer and clearing secretions from the mouth and nose using a bulb syringe.

• If the heart rate remains below 100 bpm after these interventions, positive pressure ventilation is initiated; intubation may be considered if breathing does not improve.

Management of Meconium Aspiration Syndrome

• Adequate ventilation and oxygenation are critical; supplemental oxygen is administered based on severity with target saturation levels between 95% to 98%.

• Moderate cases require FiO2 of 40%-50% without positive pressure ventilation; severe cases necessitate higher FiO2 (>50%) along with positive pressure ventilation.

Advanced Interventions

• If there’s no response to CPAP (Continuous Positive Airway Pressure), mechanical ventilation may be required for about 30% of meconium aspiration syndrome patients under sedation and analgesia.

• Surfactant therapy is indicated for severe cases needing invasive mechanical ventilation; nitric oxide can help improve oxygenation in patients showing persistent pulmonary hypertension.

Critical Care Considerations

• ECMO (Extracorporeal Membrane Oxygenation) is utilized when there's no response to invasive mechanical ventilation combined with surfactant or nitric oxide treatment.

• Maintaining adequate blood pressure and perfusion involves volume expansion using saline solutions for hypotensive patients or red blood cell transfusions to optimize tissue oxygen delivery.

Preventive Measures in Perinatal Care

• Antibiotics are reserved for patients showing evidence of infiltrates on chest X-rays.

• Preventing post-term deliveries beyond 41 weeks through induction reduces perinatal asphyxia risk. Continuous fetal monitoring helps identify signs of fetal hypoxemia or meconium-stained amniotic fluid.